| Prev Close | 8.70 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 7.41 / 24.93 |
| Avg Volume | 6.15M |
| Exchange | NASDAQ |
| Shares Outstanding | 223.29M |
| Market Cap | 1.82B |
| EPS | -15.00 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers
Geron and Endo and were among the biotech stock movers on Aug. 1.
Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis
McCaskill requested that four more drug companies and three drug distributors turn over documents.
Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid
IntelliPharmaceuticals has a bio-equivalent to OxyContin, but says it is harder to tamper with. The pharma company is hoping to gain a recommendation from an FDA committee on Wednesday.
3 Biotech Stocks on Readers' Minds
We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.
ENDP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc
The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Endo International plc ("Endo") (NASDAQ:ENDP) violated federal securities laws.
Trump's FDA: A Friendlier Biotech Sheriff
There still will be winners and losers, but the new administration's FDA is a net plus for the industry.
Endo's Potential Next Steps After Pulling Opioid Pain Med
The pharmaceutical company has opted to voluntarily remove Opana ER from the market following the FDA's request.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Endo International Plc - ENDP
Pomerantz LLP is investigating claims on behalf of investors of Endo International plc ("Endo" or the "Company") (NASDAQ:ENDP).
Biotech Movers: Alexion, Arena, Novavax
Alexion, Arena and Novavax were among the biotech stock movers ahead of the market open on Friday, July 7.
ENDP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc
The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Endo International plc ("Endo") (NASDAQ: ENDP) violated federal securities laws.
Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing
Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and "waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands of Oklahomans."
Biotech Movers: Paratek, Opko, Endo
Shares of Paratek Pharmaceuticals, Opko Health and Endo International were among the biotech stock movers in premarket trading on June 30.
2 Recovering Biotech Names With Room to Run
There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.
Opioid Marketing Under Bipartisan Investigation
Individual state investigations of opioid marketing practices has lead to a multistate investigation of the prescription painkiller industry.
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of The Commencement Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc -- ENDP
Levi & Korsinsky announces it has commenced an investigation of Endo International plc (NASDAQ: ENDP) concerning possible violations of federal securities laws.
Arons & Arons, LLC. Announces Investigation On Behalf Of Endo International Plc Investors
The Law Firm of Arons & Arons, LLC. has initiated an investigation of Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) on behalf of the company's investors for possible violations of federal securities...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors Of The Commencement Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc
Levi & Korsinsky announces it has commenced an investigation of Endo International plc (NASDAQ:ENDP) concerning possible violations of federal securities laws.
Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Endo International Plc Investors
Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) concerning the Company and its officers' possible violations of federal...
Endo Shares Down as FDA Seeks Removal of Opioid Pain Medication
This marks the first time that the FDA is seeking to remove an opioid pain medication from the market due to the public health consequences of abuse.
